semaglutide and arrhythmia Effect of on arrhythmic, major cardiovascular, renal outcomes in patients with overweight or obesity: a systematic review and meta-analysis Ozempic & AFib: The Hidden

Start by completing our online health assessment

authorised trial personnel must follow the sponsor's IMPD and comply with the Medicines for Human Use (Clinical Trials) Regulations 2004, as the MHRA has warned against purchasing unlicensed peptides from unregulated sources

GHK-Cu remains available through some 503A/503B compounding pharmacies

Why do people explore DSIP therapy

We screen for kidney function and cardiovascular health before any infusion to ensure your protocol is a safe and effective fit for your biology

The patient taking a GLP-1 Receptor Agonist for treatment of diabetes may also be taking other diabetic medication such as Metformin, Glipizide, or Jardiance